Recombinant multi-species TNFAIP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TNFAIP3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2012]
The Alternative Names of target: A20,AIFBL1,AISBL,OTU domain-containing protein 7C,OTUD7C,Putative DNA-binding protein A20,TNF alpha-induced protein 3,TNFA1P2,TNFAIP3,Tnfaip3,Tnfip3,Tumor necrosis factor alpha-induced protein 3,Zinc finger protein A20

Target products collectionGo to TNFAIP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T56474-Ag-1/ GM-Tg-hg-T56474-Ag-2 Human TNFAIP3 protein Human
GM-Tg-rg-T56474-Ag-1/ GM-Tg-rg-T56474-Ag-2 Rat TNFAIP3 protein Rat
GM-Tg-mg-T56474-Ag-1/ GM-Tg-mg-T56474-Ag-2 Mouse TNFAIP3 protein Mouse
GM-Tg-cynog-T56474-Ag-1/ GM-Tg-cynog-T56474-Ag-2 Cynomolgus/Rhesus macaque TNFAIP3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T56474-Ag-1/ GM-Tg-felg-T56474-Ag-2 Feline TNFAIP3 protein Feline
GM-Tg-cang-T56474-Ag-1/ GM-Tg-cang-T56474-Ag-2 Canine TNFAIP3 protein Canine
GM-Tg-bovg-T56474-Ag-1/ GM-Tg-bovg-T56474-Ag-2 Bovine TNFAIP3 protein Bovine
GM-Tg-equg-T56474-Ag-1/ GM-Tg-equg-T56474-Ag-2 Equine TNFAIP3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T56474-Ag-1/ GM-Tg-hg-T56474-Ag-2; GM-Tg-rg-T56474-Ag-1/ GM-Tg-rg-T56474-Ag-2;
GM-Tg-mg-T56474-Ag-1/ GM-Tg-mg-T56474-Ag-2; GM-Tg-cynog-T56474-Ag-1/ GM-Tg-cynog-T56474-Ag-2;
GM-Tg-felg-T56474-Ag-1/ GM-Tg-felg-T56474-Ag-2; GM-Tg-cang-T56474-Ag-1/ GM-Tg-cang-T56474-Ag-2;
GM-Tg-bovg-T56474-Ag-1/ GM-Tg-bovg-T56474-Ag-2; GM-Tg-equg-T56474-Ag-1/ GM-Tg-equg-T56474-Ag-2
Products Name TNFAIP3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TNFAIP3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TNFAIP3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.